Cargando…
Barrett's Esophagus: Where Do We Stand?
Barrett's esophagus (BE) is a precursor for esophageal adenocarcinoma, which has an increased incidence rate over the last few decades. Its importance stems from the poor five-year survival of esophageal adenocarcinoma and current data that suggest a survival benefit when surveillance programs...
Autor principal: | Al Madi, Majid A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702947/ https://www.ncbi.nlm.nih.gov/pubmed/19568547 http://dx.doi.org/10.4103/1319-3767.45046 |
Ejemplares similares
-
Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?
por: Mikolašević, Ivana, et al.
Publicado: (2018) -
Endoscopic therapy for Barrett’s esophagus and early esophageal cancer: Where do we go from here?
por: Singh, Tavankit, et al.
Publicado: (2018) -
Genetics of Keratoconus: Where Do We Stand?
por: Abu-Amero, Khaled K., et al.
Publicado: (2014) -
ColVI myopathies: where do we stand, where do we go?
por: Allamand, Valérie, et al.
Publicado: (2011) -
Where Do We Stand?
Publicado: (1891)